跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PHENERGAN promethazine hydrochloride 25mg tablet blister pack (reformulation) - TGA Drug Approval Details
Approvals
/
TGA
/
PHENERGAN promethazine hydrochloride 25mg tablet blister pack (reformulation)
Approved
STANDARD
PHENERGAN promethazine hydrochloride 25mg tablet blister pack (reformulation)
Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
6039499403e54d17
Company
Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare
Type
Standard
Approval Details
Approval Id
6039499403e54d17
Product Name
PHENERGAN promethazine hydrochloride 25mg tablet blister pack (reformulation)
Artg Id
80160
Artg Name
PHENERGAN promethazine hydrochloride 25mg tablet blister pack (reformulation)
Sponsor
Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare
Company Detail Path
/organization/sanofi-aventis-healthcare-pty-ltd
Artg Date
2001-09-17
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2021-CMI-01934-1
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2021-PI-01935-1
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
6039499403e54d17
Type
Standard
Back to TGA Approvals